Brief: Avadel Pharmaceuticals Q3 EPS USD -0.41
08/11/2023 12:00
Nov 08 (Reuters) - Avadel Pharmaceuticals Q3 basic EPS USD -0.41. * Q3 operating income USD -35.11 million * Q3 operating expenses USD 42.007 million * Q3 pretax profit USD -36.185 million * Q3 net income USD -36.274 million
Recent news on Avadel Pharmaceuticals
See all newsBrief: Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 08:10 AM
H Lundbeck steps down from takeover for Avadel, shares rise 3%
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet